172 related articles for article (PubMed ID: 36685546)
21. Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager.
de Sostoa J; Fajardo CA; Moreno R; Ramos MD; Farrera-Sal M; Alemany R
J Immunother Cancer; 2019 Jan; 7(1):19. PubMed ID: 30683154
[TBL] [Abstract][Full Text] [Related]
22. The CD3-gamma and CD3-delta subunits of the T cell antigen receptor can be expressed within distinct functional TCR/CD3 complexes.
Alarcón B; Ley SC; Sánchez-Madrid F; Blumberg RS; Ju ST; Fresno M; Terhorst C
EMBO J; 1991 Apr; 10(4):903-12. PubMed ID: 1826255
[TBL] [Abstract][Full Text] [Related]
23. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.
Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D
Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935
[TBL] [Abstract][Full Text] [Related]
24. Mutations to the BTN2A1 Linker Region Impact Its Homodimerization and Its Cytoplasmic Interaction with Phospho-Antigen-Bound BTN3A1.
Nguyen K; Jin Y; Howell M; Hsiao CC; Wiemer AJ; Vinogradova O
J Immunol; 2023 Jul; 211(1):23-33. PubMed ID: 37171180
[TBL] [Abstract][Full Text] [Related]
25. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
Biburger M; Weth R; Wels WS
J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
[TBL] [Abstract][Full Text] [Related]
26. Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker module.
Stamova S; Cartellieri M; Feldmann A; Arndt C; Koristka S; Bartsch H; Bippes CC; Wehner R; Schmitz M; von Bonin M; Bornhäuser M; Ehninger G; Bachmann M
Mol Immunol; 2011 Dec; 49(3):474-82. PubMed ID: 22014687
[TBL] [Abstract][Full Text] [Related]
27. Generation and characterization of monospecific and bispecific hexavalent trimerbodies.
Blanco-Toribio A; Sainz-Pastor N; Álvarez-Cienfuegos A; Merino N; Cuesta ÁM; Sánchez-Martín D; Bonet J; Santos-Valle P; Sanz L; Oliva B; Blanco FJ; Álvarez-Vallina L
MAbs; 2013; 5(1):70-9. PubMed ID: 23221741
[TBL] [Abstract][Full Text] [Related]
28. Induction of lysis by T cell receptor gamma delta+/CD3+ T lymphocytes via CD2 requires triggering via the T11.1 epitope only.
Goedegebuure PS; Segal DM; Braakman E; Vreugdenhil RJ; Van Krimpen BA; Van de Griend RJ; Bolhuis RL
J Immunol; 1989 Mar; 142(6):1797-802. PubMed ID: 2466076
[TBL] [Abstract][Full Text] [Related]
29. Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivo.
Passariello M; Yoshioka A; Takahashi K; Hashimoto SI; Inoue T; Nakamura K; De Lorenzo C
J Exp Clin Cancer Res; 2022 Sep; 41(1):269. PubMed ID: 36071464
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy based on bispecific T-cell engager with hIgG1 Fc sequence as a new therapeutic strategy in multiple myeloma.
Zou J; Chen D; Zong Y; Ye S; Tang J; Meng H; An G; Zhang X; Yang L
Cancer Sci; 2015 May; 106(5):512-21. PubMed ID: 25664501
[TBL] [Abstract][Full Text] [Related]
31. Developmental arrest of NK1.1+ T cell antigen receptor (TCR)-alpha/beta+ T cells and expansion of NK1.1+ TCR-gamma/delta+ T cell development in CD3 zeta-deficient mice.
Arase H; Ono S; Arase N; Park SY; Wakizaka K; Watanabe H; Ohno H; Saito T
J Exp Med; 1995 Sep; 182(3):891-5. PubMed ID: 7650493
[TBL] [Abstract][Full Text] [Related]
32. Distinct domains of the CD3-gamma chain are involved in surface expression and function of the T cell antigen receptor.
Wegener AM; Hou X; Dietrich J; Geisler C
J Biol Chem; 1995 Mar; 270(9):4675-80. PubMed ID: 7533164
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of T cells secreting αCD133-αCD3 bispecific T-cell engager against cholangiocarcinoma.
Sangsuwannukul T; Supimon K; Chieochansin T; Choomee K; Sujjitjoon J; Junking M; Yenchitsomanus PT
PLoS One; 2022; 17(3):e0265773. PubMed ID: 35312724
[TBL] [Abstract][Full Text] [Related]
34. Structural analysis of low TCR-CD3 complex expression in T cells of an immunodeficient patient.
Thoenes G; Soudais C; le Deist F; Griscelli C; Fischer A; Lisowska-Grospierre B
J Biol Chem; 1992 Jan; 267(1):487-93. PubMed ID: 1370449
[TBL] [Abstract][Full Text] [Related]
35. Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2
Lai AY; Patel A; Brewer F; Evans K; Johannes K; González LE; Yoo KJ; Fromm G; Wilson K; Schreiber TH; de Silva S
J Immunol; 2022 Oct; 209(8):1475-1480. PubMed ID: 36096643
[TBL] [Abstract][Full Text] [Related]
36. A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies.
Skokos D; Waite JC; Haber L; Crawford A; Hermann A; Ullman E; Slim R; Godin S; Ajithdoss D; Ye X; Wang B; Wu Q; Ramos I; Pawashe A; Canova L; Vazzana K; Ram P; Herlihy E; Ahmed H; Oswald E; Golubov J; Poon P; Havel L; Chiu D; Lazo M; Provoncha K; Yu K; Kim J; Warsaw JJ; Stokes Oristian N; Siao CJ; Dudgeon D; Huang T; Potocky T; Martin J; MacDonald D; Oyejide A; Rafique A; Poueymirou W; Kirshner JR; Smith E; Olson W; Lin J; Thurston G; Sleeman MA; Murphy AJ; Yancopoulos GD
Sci Transl Med; 2020 Jan; 12(525):. PubMed ID: 31915305
[TBL] [Abstract][Full Text] [Related]
37. CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas.
Oberst MD; Fuhrmann S; Mulgrew K; Amann M; Cheng L; Lutterbuese P; Richman L; Coats S; Baeuerle PA; Hammond SA
MAbs; 2014; 6(6):1571-84. PubMed ID: 25484061
[TBL] [Abstract][Full Text] [Related]
38. Chemically self-assembled antibody nanorings (CSANs): design and characterization of an anti-CD3 IgM biomimetic.
Li Q; So CR; Fegan A; Cody V; Sarikaya M; Vallera DA; Wagner CR
J Am Chem Soc; 2010 Dec; 132(48):17247-57. PubMed ID: 21077608
[TBL] [Abstract][Full Text] [Related]
39. CD3 delta establishes a functional link between the T cell receptor and CD8.
Doucey MA; Goffin L; Naeher D; Michielin O; Baumgärtner P; Guillaume P; Palmer E; Luescher IF
J Biol Chem; 2003 Jan; 278(5):3257-64. PubMed ID: 12215456
[TBL] [Abstract][Full Text] [Related]
40. IL-2-dependent murine T-cell lines and clones expressing gamma/delta T-cell antigen receptors. I. Functional and biochemical characterization.
Morkowski JJ; Nanno M; Chen PF; Itoh K; Ioannides CG; Kruzel E; Becker FF; Platsoucas CD
Scand J Immunol; 1991 Dec; 34(6):779-94. PubMed ID: 1836276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]